Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 2009, 59 (4): 225-249. 10.3322/caac.20006.
Article
PubMed
Google Scholar
Society AC: Breast Cancer Facts and Figures. 2009, Atlanta, GA: American Cancer Society
Google Scholar
Colburn NH, Kensler TW: Targeting transcription factors for cancer prevention--the case of Nrf2. Cancer Prev Res (Phila Pa). 2008, 1 (3): 153-155.
Article
CAS
Google Scholar
Kwon KH, Barve A, Yu S, Huang MT, Kong AN: Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models. Acta Pharmacol Sin. 2007, 28 (9): 1409-1421. 10.1111/j.1745-7254.2007.00694.x.
Article
CAS
PubMed
Google Scholar
Prince M, Li Y, Childers A, Itoh K, Yamamoto M, Kleiner HE: Comparison of citrus coumarins on carcinogen-detoxifying enzymes in Nrf2 knockout mice. Toxicol Lett. 2009, 185 (3): 180-186. 10.1016/j.toxlet.2008.12.014.
Article
CAS
PubMed
Google Scholar
Hong CC, Ambrosone CB, Ahn J, Choi JY, McCullough ML, Stevens VL, Rodriguez C, Thun MJ, Calle EE: Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2007, 16 (9): 1784-1794. 10.1158/1055-9965.EPI-07-0247.
Article
CAS
PubMed
Google Scholar
Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, Muti P, Rogan E, Russo J, Santen R, et al: Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta. 2006, 1766 (1): 63-78.
CAS
PubMed
Google Scholar
Canter JA, Kallianpur AR, Parl FF, Millikan RC: Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res. 2005, 65 (17): 8028-8033.
CAS
PubMed
Google Scholar
Zipprich J, Terry MB, Liao Y, Agrawal M, Gurvich I, Senie R, Santella RM: Plasma protein carbonyls and breast cancer risk in sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry. Cancer Res. 2009, 69 (7): 2966-2972. 10.1158/0008-5472.CAN-08-3418.
Article
CAS
PubMed
PubMed Central
Google Scholar
Row EC, Brown SA, Stachulski AV, Lennard MS: Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4. Org Biomol Chem. 2006, 4 (8): 1604-1610. 10.1039/b601096b.
Article
CAS
PubMed
Google Scholar
Caldaza, Hooz: Organic Syntheses. 1988, New York: John Wiley & Sons, Inc, 6:
Google Scholar
Aldaz CM, Liao QY, LaBate M, Johnston DA: Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene. Carcinogenesis. 1996, 17 (9): 2069-2072. 10.1093/carcin/17.9.2069.
Article
CAS
PubMed
Google Scholar
Prince M, Campbell CT, Robertson TA, Wells AJ, Kleiner HE: Naturally occurring coumarins inhibit 7,12-dimethylbenz[a]anthracene DNA adduct formation in mouse mammary gland. Carcinogenesis. 2006, 27 (6): 1204-1213. 10.1093/carcin/bgi303.
Article
CAS
PubMed
Google Scholar
Paster EV, Villines KA, Hickman DL: Endpoints for mouse abdominal tumor models: refinement of current criteria. Comp Med. 2009, 59 (3): 234-241.
CAS
PubMed
PubMed Central
Google Scholar
Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER: Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990, 186: 464-478. full_text.
Article
CAS
PubMed
Google Scholar
Russo IH, Koszalka M, Russo J: Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis. Carcinogenesis. 1990, 11 (10): 1849-1855. 10.1093/carcin/11.10.1849.
Article
CAS
PubMed
Google Scholar
Habig WH, Jakoby WB: Assays for differentiation of glutathione S-transferases. Methods Enzymol. 1981, 77: 398-405. full_text.
Article
CAS
PubMed
Google Scholar
Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X, Rowlands T, Egeblad M, Cowin P, Werb Z, et al: Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci USA. 2003, 100 (26): 15853-15858. 10.1073/pnas.2136825100.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kleiner HE, Vulimiri SV, Miller L, Johnson WH, Whitman CP, DiGiovanni J: Oral administration of naturally occurring coumarins leads to altered phase I and II enzyme activities and reduced DNA adduct formation by polycyclic aromatic hydrocarbons in various tissues of SENCAR mice. Carcinogenesis. 2001, 22 (1): 73-82. 10.1093/carcin/22.1.73.
Article
CAS
PubMed
Google Scholar
Kiguchi K, Beltran L, Rupp T, DiGiovanni J: Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol. Mol Carcinog. 1998, 22 (2): 73-83. 10.1002/(SICI)1098-2744(199806)22:2<73::AID-MC2>3.0.CO;2-L.
Article
CAS
PubMed
Google Scholar
Kwak MK, Kensler TW: Targeting NRF2 signaling for cancer chemoprevention. Toxicol Appl Pharmacol. 2010, 244 (1): 66-76. 10.1016/j.taap.2009.08.028.
Article
CAS
PubMed
Google Scholar
Jana S, Mandlekar S: Role of phase II drug metabolizing enzymes in cancer chemoprevention. Curr Drug Metab. 2009, 10 (6): 595-616.
Article
CAS
PubMed
Google Scholar
Krishnan P, Yan KJ, Windler D, Tubbs J, Grand R, Li BD, Aldaz CM, McLarty J, Kleiner-Hancock HE: Citrus auraptene suppresses cyclin D1 and significantly delays N-methyl nitrosourea induced mammary carcinogenesis in female Sprague-Dawley rats. BMC Cancer. 2009, 9: 259-10.1186/1471-2407-9-259.
Article
PubMed
PubMed Central
Google Scholar
Tusi SK, Ansari N, Amini M, Amirabad AD, Shafiee A, Khodagholi F: Attenuation of NF-kappaB and activation of Nrf2 signaling by 1,2,4-triazine derivatives, protects neuron-like PC12 cells against apoptosis. Apoptosis. 2010, 15 (6): 738-751. 10.1007/s10495-010-0496-6.
Article
CAS
PubMed
Google Scholar
Masutani H, Otsuki R, Yamaguchi Y, Takenaka M, Kanoh N, Takatera K, Kunimoto Y, Yodoi J: Fragrant unsaturated aldehydes elicit activation of the Keap1/Nrf2 system leading to the upregulation of thioredoxin expression and protection against oxidative stress. Antioxid Redox Signal. 2009, 11 (5): 949-962. 10.1089/ars.2008.2292.
Article
CAS
PubMed
Google Scholar
Funato Y, Michiue T, Asashima M, Miki H: The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled. Nat Cell Biol. 2006, 8 (5): 501-508. 10.1038/ncb1405.
Article
CAS
PubMed
Google Scholar
Solanas M, Grau L, Moral R, Vela E, Escrich R, Escrich E: Dietary olive oil and corn oil differentially affect experimental breast cancer through distinct modulation of the p21Ras signaling and the proliferation-apoptosis balance. Carcinogenesis. 31 (5): 871-879. 10.1093/carcin/bgp243.
Margineanu E, Cotrutz CE, Cotrutz C: Correlation between E-cadherin abnormal expressions in different types of cancer and the process of metastasis. Rev Med Chir Soc Med Nat Iasi. 2008, 112 (2): 432-436.
PubMed
Google Scholar
Shah FD, Shukla SN, Shah PM, Shukla HK, Patel PS: Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer. Indian J Cancer. 2009, 46 (3): 194-202. 10.4103/0019-509X.52953.
Article
CAS
PubMed
Google Scholar
Chen Y, Cai J, Jones DP: Mitochondrial thioredoxin in regulation of oxidant-induced cell death. FEBS Lett. 2006, 580 (28-29): 6596-6602. 10.1016/j.febslet.2006.11.007.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brigelius-Flohe R: Glutathione peroxidases and redox-regulated transcription factors. Biol Chem. 2006, 387 (10-11): 1329-1335. 10.1515/BC.2006.166.
CAS
PubMed
Google Scholar
Peng DF, Razvi M, Chen H, Washington K, Roessner A, Schneider-Stock R, El-Rifai W: DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. Gut. 2009, 58 (1): 5-15. 10.1136/gut.2007.146290.
Article
CAS
PubMed
Google Scholar
Hayes JD, McMahon M, Chowdhry S, Dinkova-Kostova AT: Cancer Chemoprevention Mechanisms Mediated Through the Keap1-Nrf2 Pathway. Antioxid Redox Signal. 2010, 13 (11):
Wang JS, Shen X, He X, Zhu YR, Zhang BC, Wang JB, Qian GS, Kuang SY, Zarba A, Egner PA, et al: Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. J Natl Cancer Inst. 1999, 91 (4): 347-354. 10.1093/jnci/91.4.347.
Article
CAS
PubMed
Google Scholar
Davidson NE, Egner PA, Kensler TW: Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver. Cancer Res. 1990, 50 (8): 2251-2255.
CAS
PubMed
Google Scholar
Kensler TW, Egner PA, Dolan PM, Groopman JD, Roebuck BD: Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res. 1987, 47 (16): 4271-4277.
CAS
PubMed
Google Scholar
Thimmulappa RK, Rangasamy T, Alam J, Biswal S: Dibenzoylmethane activates Nrf2-dependent detoxification pathway and inhibits benzo(a)pyrene induced DNA adducts in lungs. Med Chem. 2008, 4 (5): 473-481. 10.2174/157340608785700199.
Article
CAS
PubMed
Google Scholar
Singh A, Boldin-Adamsky S, Thimmulappa RK, Rath SK, Ashush H, Coulter J, Blackford A, Goodman SN, Bunz F, Watson WH, et al: RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Cancer Res. 2008, 68 (19): 7975-7984. 10.1158/0008-5472.CAN-08-1401.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ohta T, Iijima K, Miyamoto M, Nakahara I, Tanaka H, Ohtsuji M, Suzuki T, Kobayashi A, Yokota J, Sakiyama T, et al: Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res. 2008, 68 (5): 1303-1309. 10.1158/0008-5472.CAN-07-5003.
Article
CAS
PubMed
Google Scholar
Lau A, Villeneuve NF, Sun Z, Wong PK, Zhang DD: Dual roles of Nrf2 in cancer. Pharmacol Res. 2008, 58 (5-6): 262-270. 10.1016/j.phrs.2008.09.003.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang XJ, Sun Z, Villeneuve NF, Zhang S, Zhao F, Li Y, Chen W, Yi X, Zheng W, Wondrak GT, et al: Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis. 2008, 29 (6): 1235-1243. 10.1093/carcin/bgn095.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, et al: The consensus coding sequences of human breast and colorectal cancers. Science. 2006, 314 (5797): 268-274. 10.1126/science.1133427.
Article
PubMed
Google Scholar
Nioi P, Nguyen T: A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity. Biochem Biophys Res Commun. 2007, 362 (4): 816-821. 10.1016/j.bbrc.2007.08.051.
Article
CAS
PubMed
Google Scholar
Yates MS, Tran QT, Dolan PM, Osburn WO, Shin S, McCulloch CC, Silkworth JB, Taguchi K, Yamamoto M, Williams CR, et al: Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis. 2009, 30 (6): 1024-1031. 10.1093/carcin/bgp100.
Article
CAS
PubMed
PubMed Central
Google Scholar